MARKET WRAP: TCS up 5% in a flat market, HUL hits record, metal stocks slip
After a muted session, investors will now look out for inflation data on Thursday and Infosys results on Friday to fine-tune their trading strategy. Global developments, too, will impact sentiment
1:16 PM
Equirus on Gujarat Ambuja Exports
We analyzed Gujarat Ambuja Exports’ (GAEX) FY18 Annual Report and following were the key takeaways: (1) Demand for corn starch in the export market has increased and GAEX’s new Chalisgaon plant is primarily focussing on exports. (2) A 300bps EBITDAM expansion in the agro segment was mainly driven by a reduction in trading activities. (3) Focus remains on the maize business in terms of capital allocation. (4) Capacity utilization in the agro business is set to pick up as domestic demand for de-oiled cakes is improving. We broadly maintain our FY19/FY20 estimates and maintain our SoTP-based June’19 target price of Rs 320. Maintain Long rating.
12:58 PM
FMCG index hits new high; HUL, Godrej Consumer at record levels
Shares of fast moving consumer goods (FMCG) companies continued at their upward march on Wednesday with the Nifty FMCG index hitting a new high of 29,958 on the National Stock Exchange (NSE), fuelled by expectations of a healthy performance in June quarter, aided by a low base and a healthy underlying demand scenario. READ MORE
12:44 PM
Mukesh Ambani's aim to more than double RIL's size looks achievable
Last Thursday, Reliance Industries' chairman Mukesh Ambani exuded confidence that the company will more than double in the next seven years. At the company's annual general meeting of shareholders, Ambani said, "As India starts on its high growth journey to double the size of its economy by 2025, I assure you that the size of Reliance will more than double in the same period." READ MORE
12:36 PM
MARKET COMMENT R Sreesankar, Co-Head - Insitutional Equities, Prabhudas Lilladher
We had reduced our trading range for the market to be between estimated the trading range for the market to be between 9640-10000 and maintaining the trading range for the near term. With the country getting into an election mode in the next nine months from both the state elections as well as the general elections, the uncertainty is likely to set in. This in our view should result into a contraction of market PERs.
With crude remaining at an elevated level, the under performance of the OMCs is a case point as the market expects any further increase in crude prices may not be passed onto the consumers ahead of elections. On the contrary, there is an expectation of subsidy increases leading to an increase on overall government borrowings. In anticipation, we have already seen the bond yields moving up and interest rates inching up. With both crude as well as most global commodity prices remaining firm, it is also expected to see a commodity led inflationary pressure building up. The mid cap and small cap companies continue to see pressure
We had reduced our trading range for the market to be between estimated the trading range for the market to be between 9640-10000 and maintaining the trading range for the near term. With the country getting into an election mode in the next nine months from both the state elections as well as the general elections, the uncertainty is likely to set in. This in our view should result into a contraction of market PERs.
With crude remaining at an elevated level, the under performance of the OMCs is a case point as the market expects any further increase in crude prices may not be passed onto the consumers ahead of elections. On the contrary, there is an expectation of subsidy increases leading to an increase on overall government borrowings. In anticipation, we have already seen the bond yields moving up and interest rates inching up. With both crude as well as most global commodity prices remaining firm, it is also expected to see a commodity led inflationary pressure building up. The mid cap and small cap companies continue to see pressure
12:35 PM
Motilal Oswal Research on Ipca Labs
We have assumed strong 13.5%/44% CAGR in sales and PAT over FY18-20. We raise our target P/E multiple to 21x (from 20x earlier) on back of enhanced visibility of regulatory resolution based on remediation work done by the company, revival in DF and anti-malaria business. Accordingly, we value IPCA at 21x FY20E EPS of Rs 39 to arrive at a price target of Rs 825 (v/s INR785; 20x FY20E EPS earlier). Reiterate Buy.
12:21 PM
Paisa Bazaar under Sebi scanner over Akshay Kumar ad promoting MFs
Popular online distribution portal Paisa Bazaar's latest advertisements featuring Akshay Kumar to promote mutual funds have come under regulatory glare.
Sources said industry body Association of Mutual Funds in India (AMFI) had directed Paisa Bazaar to seek an approval from markets regulator Securities and Exchange Board of India (Sebi) for commercials featuring celebrities. However, the ads have already gone live on popular social media platforms. READ MORE
12:08 PM
Market Check
S&P BSE Sensex | 36,265.10 | 0.07% | |
Nifty 50 | 10,946.90 | -0.00% | |
S&P BSE 200 | 4,704.63 | -0.06% | |
Nifty 500 | 9,346.75 | -0.14% | |
S&P BSE Mid-Cap | 15,672.35 | -0.42% | |
S&P BSE Small-Cap | 16,454.71 | -0.18% |
11:50 AM
Emkay Global on pharma sector
Recent price rise in the US Pharma industry has drawn a sharp reaction from the US President Donald Trump with a pledge to respond with various appropriate measures. The Trump administration blames high US drug prices on lower prices as well as pricing caps in other countries, leading to Americans subsidizing the high R&D costs. Given this US stance, the recent attempts by the Indian government to rein in drug prices could now become a bone of contention between the two governments. Recent attempts by the US generic drug industry to push back against severe price erosion by hiking prices could also come under scrutiny.
11:35 AM
Choice Research on Asian Paints
11:30 AM
Market check
Index | Current | Pt. Change | % Change |
S&P BSE SENSEX | 36,190.11 | -49.51 | -0.14 |
S&P BSE SENSEX 50 | 11,453.63 | -10.78 | -0.09 |
S&P BSE SENSEX Next 50 | 32,335.60 | -221.02 | -0.68 |
S&P BSE 100 | 11,199.10 | -20.27 | -0.18 |
S&P BSE Bharat 22 Index | 3,356.61 | -23.29 | -0.69 |
11:23 AM
MUST READ As auto sector continues to grow, Nano's failure stands in stark contrast
A moment of silence, please, for the world’s cheapest car, which has all but died in India. It was almost 10 years old. The Nano’s death was confirmed by production numbers: Tata Motors Ltd. produced 1 unit in June, down from 275 in the same month last year. Exports were zero, versus 25 in June 2017. The company acknowledged that the car in its “present form cannot continue beyond 2019. READ MORE HERE
11:11 AM
COMMODITY WATCH US says import of Iranian oil sanctionable from Nov 4; India may get relief
US Secretary of State Mike Pompeo said on Tuesday that the import of oil from Iran beginning November 4 will be a sanctionable activity but the US would consider the request for relief from a handful of countries, in an apparent reference to India which is the second largest buyer of Iranian crude. READ MORE
11:01 AM
PNB Housing rises 6% as PNB, Carlyle Group plan to offload 51% stake
Shares of PNB Housing Finance were up by 6% at Rs 1,269 per share on Wednesday in intra-day trade, extending their 2% rise in the previous day on the BSE, after the company said that Punjab National Bank (PNB) and the Carlyle Group proposed to sell their stake to the potential acquirers. READ MORE
10:45 AM
Emerging-Market rally pits Morgan Stanley against Goldman Sachs
Signs of stabilization in emerging markets since the start of the month are splitting some of Wall Street’s biggest banks on the outlook for the asset class. Morgan Stanley strategists dubbed the recent recovery a “head fake” and recommended selling on gains in stocks and bonds. Their counterparts at Goldman Sachs Group say that developing nations “now offer relative value” and are keeping their long call on the MSCI Emerging Markets Index of equities. READ MORE
10:29 AM
Shilpa Medicare surges 13% after receiving EIR from USFDA
Shares of Shilpa Medicare have surged by 13% to Rs 434 per share on the BSE in morning trade after the company said that it has received Establishment Inspection Report (EIR) from the US health regulator for both of its facilities located at Raichur, Karnataka. READ MORE
Topics :
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 11 2018 | 8:25 AM IST